Total 10 articles.

Articles

Ahonen A, Joensuu  H. Can FDG uptake reveal poorly differentiated  metastases of thyroid cancer survived after 131I treatment? Nuklearmedizin, Suppl 472, 1987.

Ahonen A, Joensuu H. Can FDG uptake reveal poorly differentiated metastases of thyroid cancer survived after 131I treatment ? Nuklearmedizin 1987; suppl 472.

Ahonen A, Minn H, Joensuu H, Kortekangas A, Paul R, Klemi P,Nordman E. Response of head and neck tumors to radiotherapy. Evaluation by (18F)fluorodeoxyglucose (FDG) imaging and DNA flow cytometry (FCM). In: Nuklearmedizin, Proc ENMC. Schauttauer 1988;550-553.

Heselius S-J., Malmborg P., Solin O. and Långström B., Studies of Proton Beam Penetration in Nitrogen-gas Targets with Respect to Production and Specific Radioactivity of Carbon-11, Appl. Radiat. Isot. 38.49, 1987.

Joensuu H, Ahonen A. Imaging of metastases  of  thyroid carcinoma  with fluorine-18 fluorodeoxyglucose.  J  Nucl  Med 28: 910-914,  1987.

Joensuu H, Ahonen A. Imaging of metastases of tyroid carcinoma with fluorine-18-fluorodeoxyglucose . J Nucl Med 1987;28:910-914.

Martin WRW, Stoessl AJ, Adam MJ, Ammann W, Bergström M, Harrop R,  Laihinen A,Rogers JG, Ruth TJ, Sayre CI,  Pate BD, Calne DB. Positron emissiontomography  in  Parkinson's disease. Advances in  Neurology, Vol 45, eds YahrMD and Bergman KJ.  Raven  Press, New  York, pp 95-98, 1987.

Paul R. Comparison of (18F)-2-fluorodeoxyglucose and (67Ga)citrate for detection of lymphoma. J Nucl Med 28:288-292; 1987 [4.015]

Paul R, Kiuru A, Söderström KO, Tuominen J, Johansson R, Haaparanta M, Roeda D, Solin O. Organ and tumor distribution of 18F- 2-fluoro- deoxy-D-glucose in fasting and non-fasting rats. Life Sciences 1987;40:1609-1616.

Syvälahti E, Ahonen A, Paul R.  Positron  emission  tomography in  psychiatry and psychopharmacology. Psychiatria  Fennica 18:  87-96, 1987. Review.